🇺🇸 FDA
Patent

US 10149836

Isoxazole treatments for frontotemporal dementia

granted A61KA61K31/404A61K31/42

Quick answer

US patent 10149836 (Isoxazole treatments for frontotemporal dementia) held by The Board of Regents of the University of Texas System expires Mon Dec 06 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Dec 11 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 06 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K31/404, A61K31/42, A61K31/422, A61K31/423